These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18783791)

  • 1. Predictors of response to proton pump inhibitor therapy among children with significant esophageal eosinophilia.
    Dranove JE; Horn DS; Davis MA; Kernek KM; Gupta SK
    J Pediatr; 2009 Jan; 154(1):96-100. PubMed ID: 18783791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial.
    Dohil R; Newbury R; Fox L; Bastian J; Aceves S
    Gastroenterology; 2010 Aug; 139(2):418-29. PubMed ID: 20457157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with high-dose proton pump inhibitors helps distinguish eosinophilic esophagitis from noneosinophilic esophagitis.
    Sayej WN; Patel R; Baker RD; Tron E; Baker SS
    J Pediatr Gastroenterol Nutr; 2009 Oct; 49(4):393-9. PubMed ID: 19633574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical presentation of patients with eosinophilic inflammation of the esophagus.
    Baxi S; Gupta SK; Swigonski N; Fitzgerald JF
    Gastrointest Endosc; 2006 Oct; 64(4):473-8. PubMed ID: 16996334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults.
    Molina-Infante J; Ferrando-Lamana L; Ripoll C; Hernandez-Alonso M; Mateos JM; Fernandez-Bermejo M; Dueñas C; Fernandez-Gonzalez N; Quintana EM; Gonzalez-Nuñez MA
    Clin Gastroenterol Hepatol; 2011 Feb; 9(2):110-7. PubMed ID: 20920599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis.
    van Rhijn BD; Weijenborg PW; Verheij J; van den Bergh Weerman MA; Verseijden C; van den Wijngaard RM; de Jonge WJ; Smout AJ; Bredenoord AJ
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1815-23.e2. PubMed ID: 24657840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathologic variability in children with eosinophilic esophagitis.
    Shah A; Kagalwalla AF; Gonsalves N; Melin-Aldana H; Li BU; Hirano I
    Am J Gastroenterol; 2009 Mar; 104(3):716-21. PubMed ID: 19209168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children.
    Aceves SS; Bastian JF; Newbury RO; Dohil R
    Am J Gastroenterol; 2007 Oct; 102(10):2271-9; quiz 2280. PubMed ID: 17581266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Prevalence of Response to Proton-pump Inhibitor Treatment in Children With Esophageal Eosinophilia.
    Gutiérrez-Junquera C; Fernández-Fernández S; Cilleruelo ML; Rayo A; Echeverría L; Quevedo S; Bracamonte T; Román E
    J Pediatr Gastroenterol Nutr; 2016 May; 62(5):704-10. PubMed ID: 26513622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Loss of Response in Proton Pump Inhibitor-Responsive Esophageal Eosinophilia Is Uncommon and Influenced by CYP2C19 Genotype and Rhinoconjunctivitis.
    Molina-Infante J; Rodriguez-Sanchez J; Martinek J; van Rhijn BD; Krajciova J; Rivas MD; Barrio J; Moawad FJ; Martinez-Alcalá C; Bredenoord AJ; Zamorano J; Dellon ES
    Am J Gastroenterol; 2015 Nov; 110(11):1567-75. PubMed ID: 26416193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathologic variability and endoscopic correlates in adults with eosinophilic esophagitis.
    Gonsalves N; Policarpio-Nicolas M; Zhang Q; Rao MS; Hirano I
    Gastrointest Endosc; 2006 Sep; 64(3):313-9. PubMed ID: 16923475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of proton pump inhibitor on esophageal eosinophilia.
    Schroeder S; Capocelli KE; Masterson JC; Harris R; Protheroe C; Lee JJ; Furuta GT
    J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):166-72. PubMed ID: 23325438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between baseline impedance values and response proton pump inhibitors in patients with heartburn.
    de Bortoli N; Martinucci I; Savarino E; Tutuian R; Frazzoni M; Piaggi P; Bertani L; Furnari M; Franchi R; Russo S; Bellini M; Savarino V; Marchi S
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1082-8.e1. PubMed ID: 25499991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review article: proton pump inhibitor therapy for suspected eosinophilic oesophagitis.
    Molina-Infante J; Katzka DA; Gisbert JP
    Aliment Pharmacol Ther; 2013 Jun; 37(12):1157-64. PubMed ID: 23656497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of response to short-term proton pump inhibitor treatment in laryngopharyngeal reflux patients.
    Siupsinskiene N; Adamonis K; Toohill RJ; Sereika R
    J Laryngol Otol; 2008 Nov; 122(11):1206-12. PubMed ID: 18331659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trial: Radiofrequency energy delivery in proton pump inhibitor-dependent gastro-oesophageal reflux disease patients.
    Coron E; Sebille V; Cadiot G; Zerbib F; Ducrotte P; Ducrot F; Pouderoux P; Arts J; Le Rhun M; Piche T; Bruley des Varannes S; Galmiche JP;
    Aliment Pharmacol Ther; 2008 Nov; 28(9):1147-58. PubMed ID: 18616516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
    Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
    Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitor responsive esophageal eosinophilia, a distinct disease entity?
    Munday W; Zhang X
    World J Gastroenterol; 2014 Aug; 20(30):10419-24. PubMed ID: 25132757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cysteinyl leukotriene levels in esophageal mucosal biopsies of children with eosinophilic inflammation: are they all the same?
    Gupta SK; Peters-Golden M; Fitzgerald JF; Croffie JM; Pfefferkorn MD; Molleston JP; Corkins MR; Lim JR
    Am J Gastroenterol; 2006 May; 101(5):1125-8. PubMed ID: 16573772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptome analysis of proton pump inhibitor-responsive esophageal eosinophilia reveals proton pump inhibitor-reversible allergic inflammation.
    Wen T; Dellon ES; Moawad FJ; Furuta GT; Aceves SS; Rothenberg ME
    J Allergy Clin Immunol; 2015 Jan; 135(1):187-97. PubMed ID: 25441638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.